NSEPress Release14 Jul 2026 · 14 Jul 2026, 09:29 am
Press Release
Lupin Limited · LUPIN
✦ AI SummaryESG
Lupin Limited has been recognized as one of India's Best Employers in the Nation-Builders Category by Great Place To Work India 2026, ranking among the top 14 organizations nationally.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Lupin Limited has informed the Exchange regarding a press release dated July 14, 2026, titled "Lupin Recognized Among India s Best Employers in the Nation-Builders Category by Great Place To Work® India 2026 ".
Attachments (1)
📄pdf
Download →
Lupin2_14072026092917_Indias_Best_Employers.pdf
View document text
July 14, 2026
National Stock Exchange of India Limited BSE Limited
Exchange Plaza, P. J. Towers, Dalal Street,
Bandra Kurla Complex, Mumbai Samachar Marg,
Bandra (East), Mumbai - 400 001
Mumbai - 400 051
Symbol: LUPIN Scrip Code: Equity - 500257
Subject: Disclosure pursuant to Regulation 30 of the Securities and Exchange Board of India
(Listing Obligations and Disclosure Requirements) Regulations, 2015
Dear Sir/Madam,
We are pleased to enclose a Press Release titled “Lupin Recognized Among India’s Best Employers in the Nation-
Builders Category by Great Place To Work® India 2026”.
The same is for your information and dissemination.
Thanking you,
For LUPIN LIMITED
AMIT KUMAR GUPTA
COMPANY SECRETARY & COMPLIANCE OFFICER
(ACS -15754)
Encl.: a/a.
LUPIN LIMITED
Registered Office: 3rd Floor, Kalpataru Inspire, Off W. E. Highway, Santacruz (East), Mumbai - 400 055 India. Tel: (91-22) 6640 2323.
Corporate Identity Number: L24100MH1983PLC029442 info@lupin.com | www.lupin.com
Press Release
BSE: 500257 NSE: LUPIN REUTERS: LUPIN.BO BLOOMBERG: LPCIN
Lupin Recognized Among India’s Best Employers in the Nation-Builders Category by
Great Place To Work® India 2026
Ranks Among Top 14 Organizations Nationally in the Nation Builders Category
Mumbai, July 14, 2026: Global pharma major Lupin Limited (Lupin) today announced that it has been
recognized among India’s Best Employers in the Na(cid:415)on Builders Category 2026 by Great Place To
Work® India, ranking among the Top 14 organiza(cid:415)ons na(cid:415)onally. This recogni(cid:415)on reflects Lupin’s
enduring commitment to fostering a culture based on purpose, trust, and inclusion, while
contribu(cid:415)ng to na(cid:415)on-building by expanding access to healthcare, advancing community
development, and driving meaningful societal impact.
The Na(cid:415)on Builders category recognizes organiza(cid:415)ons whose impact extends beyond business
performance through their contribu(cid:415)on to employment, people development, community
advancement and na(cid:415)on-building, while fostering excep(cid:415)onal workplace cultures.
Speaking on the occasion, Yashwant Mahadik, President – Global Human Resources, Lupin, said,
“We are honored by this recogni(cid:415)on, which celebrates the culture our people bring to life every day.
At Lupin, we are focused on crea(cid:415)ng an environment where individuals feel supported, empowered,
and connected to a shared purpose. By inves(cid:415)ng in our people and their growth, we are building a
workplace that enables meaningful contribu(cid:415)ons to pa(cid:415)ents, communi(cid:415)es, and society.
Organizations featured in this category are evaluated through a rigorous, independent assessment
conducted by Great Place To Work® India. The selection is based on the Trust Index™, which
considers employee experience, Culture Audit™ evaluations of people practices, and eligibility
criteria that assess an organization’s broader contribution to nation-building.
Through its people-first philosophy and unwavering focus on improving patient lives, Lupin continues
to create value that extends well beyond business performance.
About Lupin
Lupin Limited is a global pharmaceutical leader headquartered in Mumbai, India, with products distributed in over 100
markets. Lupin specializes in pharmaceutical products, including branded and generic formulations, complex generics,
biotechnology products, and active pharmaceutical ingredients. Trusted by healthcare professionals and consumers
globally, the company enjoys a strong position in India and the U.S. across multiple therapy areas, including respiratory,
cardiovascular, anti-diabetic, anti-infective, gastrointestinal, central nervous system, and women’s health. Lupin has 15
state-of-the-art manufacturing sites and 7 research centers globally, along with a dedicated workforce of over 26,000
professionals. Lupin is committed to improving patient health outcomes through its subsidiaries - Lupin Diagnostics,
Lupin Digital Health, and Lupin Manufacturing Solutions.
To know more, visit www.lupin.com or follow us on LinkedIn https://www.linkedin.com/company/lupin
Page 1 of 2
Press Release
BSE: 500257 NSE: LUPIN REUTERS: LUPIN.BO BLOOMBERG: LPCIN
For further information or queries please contact:
Rajalakshmi Azariah
Vice President & Global Head – Corporate Communications, Lupin
rajalakshmiazariah@lupin.com
Page 2 of 2